C24H24N6O2
Neat
428.49
Olmesartan Medoxomil Related Compound A
+5°C
Room Temperature
6, 6-Dimethyl-2-propyl-3-[[2-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]-3, 6-dihydro-4H-furo[3, 4-d]imidazol-4-one, Olmesartan Medoxomil Imp. B (EP), 4H-Furo[3, 4-d]imidazol-4-one, 3, 6-dihydro-6, 6-dimethyl-2-propyl-3-[[2-(2H-tetrazol-5-yl)[1, 1-biphenyl]-4-yl]methyl]-, 4H-Furo[3, 4-d]imidazol-4-one, 3, 6-dihydro-6, 6-dimethyl-2-propyl-3-[[2-(1H-tetrazol-5-yl)[1, 1-biphenyl]-4-yl]methyl]- (9CI), 1-{[2-(1H-Tetrazol-5-yl)biphenyl-4-yl]methyl}-4, 4-dimethyl-2-propyl-1H-furo[3, 4-d]imidazol-6(4H)-one, Olmesartan Medoxomil RC A (USP), Olmesartan Medoxomil Related Compound A and Olmesartan Medoxomil Impurity B
CCCc1nc2c(C(=O)OC2(C)C)n1Cc3ccc(cc3)c4ccccc4c5nnn[nH]5
6,6-dimethyl-2-propyl-3-[[4-[2-(1H-tetrazol-5-yl)phenyl]phenyl]methyl]furo[3,4-d]imidazol-4-one